The urinary antiseptic methenamine hippurate (Hiprex) was non-inferior to antibiotic prophylaxis in women with a history of recurrent urinary tract infections (UTI), according to results from the ...

We will update the NICE guideline on urinary tract infection (recurrent): antimicrobial prescribing. The update will focus on methenamine hippurate as prophylaxis against recurrent urinary tract ...

The antiseptic methenamine hippurate (MH) is known to sterilise urine and has been suggested of use to prevent urinary tract infections (UTIs), but firm evidence has so far been lacking. Now ...

Its use as an alternative to antibiotics may also help tackle the global burden of antibiotic resistance, say the researchers. Over half of women have at least one urinary tract infection (UTI) in ...

While primary care physicians are generally comfortable prescribing vaginal estrogen therapy for recurrent urinary tract infections (UTIs), other nonantibiotic prophylactic options remain ...

The antiseptic drug methenamine hippurate is as good as antibiotics for preventing recurrent urinary tract infections in women, finds a trial published by The BMJ today. Its use as an alternative to ...

Discover comprehensive details about Methenamine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

EQL's key product methenamine hippurate has now been launched in Germany by EQL's license partner Dr Pfleger under the EQL-owned brand Cystohipp ©. Cystohipp© is the only methenamine hippurate product ...

People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...